Moolec Science (MLEC) Projected to Post Earnings on Tuesday

Moolec Science (NASDAQ:MLEC) is anticipated to release its results before the market opens on Tuesday, April 14th. Analysts expect Moolec Science to post earnings of ($16.50) per share and revenue of $4.3870 million for the quarter.

Moolec Science Stock Performance

Shares of MLEC stock opened at $11.44 on Tuesday. Moolec Science has a 52-week low of $3.08 and a 52-week high of $157.05. The stock has a market cap of $8.31 million, a PE ratio of -0.35 and a beta of -0.36. The firm’s 50 day moving average price is $9.00 and its two-hundred day moving average price is $8.59.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of Moolec Science to a “sell” rating in a report on Saturday, February 28th.

Institutional Investors Weigh In On Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in Moolec Science SA (NASDAQ:MLEC) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.